Official ILDS COVID-19 Statement
ILDS Statement on the Coronavirus (Covid-19) Outbreak: sharing resources and guidance for the dermatology community
ILDS Statement on the Coronavirus (Covid-19) Outbreak: sharing resources and guidance for the dermatology community
Learn more about how ILDS and our Members and Partners have adapted to the challenges working in a COVID-19 world
PsoPROTECT is a new global registry established to assess outcomes of COVID-19 in patients with psoriasis
The SECURE-AD registry collects de-identified data of atopic dermatitis (AD) patients with a confirmed Covid-19 infection episode
A collaboration between ILDS and AAD: Dermatologic Manifestations of COVID-19, and existing dermatologic conditions in the setting of COVID-19
The SECURE-Alopecia registry collects de-identified data of patients with alopecia (including alopecia areata and other alopecias)